Defective system made indiscreet over production of copy drugs.

It is pointed out that the recent indiscreet production of too many copy drugs should be blamed for several defective administrative systems including 1) the current drug pricing system to allow 80% of the upper limited price for the copy drug on the original product and then the prices for copy drugs to follow on to reduce diminishingly, 2) the joint and assigned bio equivalency test system en...